Showing results (831-840 of 1,008) with videos related to
Sort By:
Pageof 101
Science Advances|July 3, 2021
Changes in global terrestrial live biomass over the 21st centuryLiang Xu, Sassan S Saatchi, Yan Yang, et al.Open Forum Infectious Diseases|August 29, 2018
Mass Azithromycin Distribution and Community Microbiome: A Cluster-Randomized TrialThuy Doan, Armin Hinterwirth, Ahmed M Arzika, et al.Head & Neck|February 4, 2009
Advanced squamous cell carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapyDouglas B Chepeha, Assuntina G Sacco, Lance E Oxford, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2017
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II StudyJoshua Bauml, Tanguy Y Seiwert, David G Pfister, et al.Oral Oncology|August 18, 2016
Predictors of severe long-term toxicity after re-irradiation for head and neck cancerJae Y Lee, Krithika Suresh, Rebecca Nguyen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2022
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404)Alan L Ho, Nathan R Foster, Alex J Zoroufy, et al.Nature Medicine|August 14, 2019
Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distributionT Doan, A Hinterwirth, L Worden, et al.Oncotarget|July 1, 2021
Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinomaCatherine T Haring, Chandan Bhambhani, Collin Brummel, et al.Cancer|June 28, 2019
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trialRobert Haddad, Fernando Concha-Benavente, George Blumenschein, et al.Preventive Medicine|November 28, 2002
Evaluation of a community breast screening promotion programJohn K Worden, Ruth M Mickey, Pamela M Vacek, et al.Pageof 101